awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50047295-EF583447-89DA-406F-A0CF-44F0ACCCECBF
Q50047295-EF583447-89DA-406F-A0CF-44F0ACCCECBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50047295-EF583447-89DA-406F-A0CF-44F0ACCCECBF
Alirocumab versus usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial.
P2860
Q50047295-EF583447-89DA-406F-A0CF-44F0ACCCECBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50047295-EF583447-89DA-406F-A0CF-44F0ACCCECBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e761402bd570f3174e4651db364b292adb7d0a31
P2860
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.